News
News
- Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base
12/06/2021 / 07:37 - GlobeNewswire - Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
12/05/2021 / 18:21 - GlobeNewswire - Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
09/01/2021 / 08:01 - GlobeNewswire - Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine
08/23/2021 / 13:45 - GlobeNewswire - Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
08/23/2021 / 07:00 - GlobeNewswire - Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
08/09/2021 / 07:00 - GlobeNewswire - Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
06/11/2021 / 19:12 - GlobeNewswire - Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-in-Human Trial
03/08/2021 / 07:00 - GlobeNewswire - Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
12/16/2020 / 20:51 - GlobeNewswire - Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine
08/24/2020 / 21:22 - GlobeNewswire
Real-time